3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
CNS
1
Conditions
Endometrial Neoplasms
15
Ovarian Neoplasms
5
Uterine Cervical Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms
4
Endometrial Hyperplasia
3
Pancreatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Interventions
Carboplatin
19
Paclitaxel
17
Cisplatin
9
Gemcitabine
7
Cyclophosphamide
7
Bevacizumab
6
Topotecan
5
pembrolizumab
4
olaparib
4
liposomal doxorubicin
4
durvalumab
4
Letrozole
4
Interleukin-2
4
Drug Therapy
4
Doxorubicin
4
Albumin-Bound Paclitaxel
4
rucaparib
3
fludarabine
3
chiauranib
3
cemiplimab
3
camrelizumab
3
Therapeutics
3
Itraconazole
3
Injections
3
Hyperthermic Intraperitoneal Chemotherapy
3
Everolimus
3
pazopanib
2
iniparib
2
eprenetapopt
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Metformin
×
Gynecologic
×
Clear all
NCT03538704
2018-05-29
ECFerSp
Peking University People's Hospital
Phase NA
Unknown
80 enrolled